Case Against UnitedHealth Group for Alleged Inflation of Part C Risk Scores is Permitted to Proceed

Recent press coverage misleadingly suggested that the ruling was a serious setback to the government’s suit, which is not the case.

On Feb. 12, 2018, a federal judge in the Central District of California issued his ruling on the UnitedHealth Group’s (UHG) motion to dismiss the government’s complaint in one of the largest False Claims Act (FCA) cases to date involving the Medicare managed care program. 

In his ruling, the judge denied UHG’s motion to dismiss as to some of the government’s claims and granted UHG’s motion as to others, while providing leave for the government to amend its complaint to resuscitate the latter claims. The net effect of the judge’s ruling, therefore, is that the government’s case against UHG is allowed to proceed, and the litigation continues. This point bears particular emphasis here, since much of the press coverage over the past few weeks has misleadingly suggested that the ruling was somehow fatal and/or a serious setback to the government’s suit, which is not the case.

A quick reminder on what this case is all about: In this case against UnitedHealth Group and its data arm, Optum, the United States is alleging that UHG submitted false diagnosis codes to the Centers for Medicare & Medicaid Services (CMS) to garner higher reimbursement rates. The alleged fraud was brought to light by whistleblower Benjamin Poehling, a former employee in the finance department of UHG’s Medicare and retirement division.

Medicare Part C reimburses insurers based on the demographics and health status of the population of CMS beneficiaries they insure in the form of a capitation rate. (This is distinct from Medicare Parts A and B, dubbed “fee-for-service” or “traditional” Medicare, which reimburses healthcare providers for services they provide.) Under Medicare Part C, insurers generally receive higher payments for covering sicker beneficiaries, regardless of what services they actually provide to those beneficiaries. Under the program’s rules, for a diagnosis to be valid it must have come from a face-to-face encounter with a qualified provider type in the given year of service, and also the diagnosed condition must have been treated or affected treatment. Also, Part C plans must submit an annual attestation, signed by the plan’s chief executive officer (CEO) or chief financial officer (CFO), certifying that all data submitted to CMS was truthful, accurate, and complete.

According to the U.S. Department of Justice (DOJ), after submitting to CMS diagnoses it received from providers, UHG then went back into patient charts and hired medical coders to do “blind” chart reviews, meaning that coders were asked to write down all diagnoses codes supported in the charts. UHG then also submitted those codes to CMS for reimbursement. The government alleges UHG generally did not delete provider-generated codes that were not supported by its chart reviews, instead only adding new codes its reviewers discovered. For example, according to the government’s complaint, if a provider submitted diagnosis codes 1 and 2, and the chart reviewer found codes 2 and 3, UHG would submit codes 1, 2, and 3, even though UHG had knowledge of code 1 being highly suspect, since it failed an audit. UHG did this on a massive scale, the government alleges, with the chart review program generating hundreds of millions of dollars a year for UHG. Additionally, UHG executives are alleged to have signed annual attestations certifying all data as truthful, accurate, and complete despite knowledge of the massive chart review program. The complaint notes that, for just dates of service (DOS) years 2010 to 2013, United should have deleted over a billion dollars in false diagnosis codes. The allegations in the complaint cover DOS years 2008 to present.

Defendants moved to dismiss the government’s complaint based on materiality, arguing that potentially false codes and potentially false attestations would not affect the government’s decision to pay UHG based on the data and therefore were not material. Defendants also argued that CMS knew all about their data-mining programs and did not cease payment. The federal judge ruled that the diagnoses submitted to CMS were material, but that DOJ inadequately pled to the materiality of the annual attestations, noting that DOJ did not allege that CMS would have stopped payment if it knew an attestation was false.

Although the dismissal was without prejudice, the government recently notified the court it would not seek to amend its complaint, instead proceeding on the claims remaining in the government’s complaint.

Next up is a scheduling conference at which the judge is expected to provide a date for when this important matter will proceed to trial.

 

Comment on this article

Facebook
Twitter
LinkedIn

Mary Inman, Esq.

Mary Inman is a partner and co-founder of Whistleblower Partners LLP, a law firm dedicated to representing whistleblowers under the various U.S. whistleblower reward programs. Mary and her colleagues have pioneered a series of successful whistleblower cases against prominent health insurers, hospitals, provider groups, and vendors under the False Claims Act alleging manipulation of the risk scores of Medicare Advantage patients. Mary is a recognized expert and frequent author, commentator, and speaker on frauds in the healthcare industry, particularly those exposed by whistleblowers. Mary is a member of the RACmonitor editorial board and a popular panelist on Monitor Monday.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Inpatient Ulcers and Gangrene: Avoid FY 2027 ICD-10-CM Coding, Sequencing, and Documentation Errors

Avoid costly inpatient coding errors involving ulcers and gangrene. This practical FY 2027 ICD-10-CM webcast clarifies pressure injury staging, non-pressure ulcer severity, diagnosis sequencing, documentation requirements, and POA reporting. Through real-world cases, gain the confidence to make defensible coding decisions, reduce denials, strengthen compliance, and support accurate reimbursement.

November 4, 2026

One Chart, Five Truths: How CDI Prevents the Same Diagnosis from Becoming Five Different Outcomes

What happens when everyone reviews the same chart, but reaches a different conclusion? In this case-based clinical documentation integrity (CDI) webcast, Penny Jefferson examines how documentation involving clinical support, timing, causation, linkage, and terminology can produce very different outcomes for ICD-10 coding, reimbursement, quality, risk adjustment, medical necessity, denials, and compliance. Using cases involving postoperative respiratory failure, severe malnutrition, and encephalopathy, you’ll learn the practical CLEAR framework to help attendees learn to evaluate whether a diagnosis is codeable, consistent, specific, reportable, and ultimately defensible across the different teams and systems that rely on the medical record.

September 30, 2026

Mastering Spinal Fusion Coding for Inpatient Facilities: ICD-10-PCS Precision, Documentation, and MS-DRG Impact

Spinal fusion cases are among the most complex inpatient procedures to code, where even minor ICD-10-PCS errors can affect MS-DRG assignment, reimbursement, compliance, and audit outcomes. This practical webcast provides a step-by-step framework for interpreting operative reports, assigning accurate ICD-10-PCS codes, recognizing documentation gaps, and confidently coding complex fusion procedures. You’ll leave with practical tools that improve coding accuracy, reduce denials and audit risk, and strengthen documentation-driven reimbursement decisions.

July 29, 2026

Trending News

Featured Webcasts

Radiation Oncology Fundamentals: Coding, Billing & Compliance for Hospital Outpatient & Professional Services

Now Available On Demand

Join Michael Calahan, PA, MBA for this radiation oncology coding and compliance webcast as he explains the fundamentals of coding, billing, reporting, and documentation for hospital outpatient and professional services. Learn how the 2026 radiation therapy coding changes affect current practices, how to distinguish technical and professional services, and how to address bundling, units, frequency, modifiers, and documentation requirements. Michael will also help you identify radiation oncology coding and billing vulnerabilities that could lead to denials, overpayments, repayment demands, or federal audit exposure.

October 20, 2026

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24